Fifty patients with early cervical cancer ( FIGO stages IA@ , IB@ , IIA < @ cm ) or locally advanced cervical cancer ( FIGO stages IB@ , IIA > @cm , IIB ) who received neoadjuvant treatment ( chemotherapy or radiochemotherapy ) and demonstrated a complete or partial clinical response and early stage endometrioid endometrial cancer ( FIGO stages IB , II ) were randomly assigned to undergo TB ( arm A ) or SES ( arm B ) .